-
Mashup Score: 2
The ACIP is a federal advisory committee composed of medical and public health experts who make recommendations on the use of vaccines for adults and children in the US.
Source: www.empr.comCategories: General Medicine NewsTweet
-
Mashup Score: 0Enflonsia Approved for RSV Disease Prevention in Infants - 25 day(s) ago
Enflonsia is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.
Source: www.empr.comCategories: General Medicine NewsTweet-
Treatment approved to protect newborns from respiratory syncytial virus. https://t.co/Efp2NWEAUO
-
-
Mashup Score: 0
Widaplik is indicated for the treatment of hypertension, including as initial treatment, to lower blood pressure.
Source: www.empr.comCategories: General Medicine NewsTweet-
Single pill combo therapy approved to treat hypertension. https://t.co/b3V9WfEbfF https://t.co/Jz5YFvzAff
-
-
Mashup Score: 0
The approval was supported by data from the randomized, double-blind, placebo-controlled, phase 3 ARANOTE trial.
Source: www.empr.comCategories: General Medicine NewsTweet-
Approval expanded for prostate cancer treatment Nubeqa. https://t.co/OAmscyZR2x https://t.co/Bpi60bgPDd
-
-
Mashup Score: 0FDA Drug Approval Decisions Expected in July 2025 - 29 day(s) ago
The FDA is expected to decide on treatments for multiple myeloma, NSCLC, melanoma, phenylketonuria, and 2 rare kidney diseases.
Source: www.empr.comCategories: General Medicine News, General Journals & SocietTweet-
View all the drug approval decisions expected to take place in July. https://t.co/e5MUwDOqtt https://t.co/8Bs9PODxtZ
-
-
Mashup Score: 0FDA Approves Moderna's Next-Generation COVID-19 Vaccine mNexspike - 1 month(s) ago
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that puts them at high risk.
Source: www.empr.comCategories: General Medicine NewsTweet-
The new vaccine is indicated for active immunization to prevent COVID-19 in individuals who have been previously vaccinated with any COVID-19 vaccine. https://t.co/VQGraTaHou https://t.co/sY97CWqTsp
-
-
Mashup Score: 1Atacicept Significantly Reduces Proteinuria in IgA Nephropathy Trial - 1 month(s) ago
Atacicept is an investigational BAFF (B-cell activating factor)/APRIL (a proliferation-inducing ligand) dual inhibitor.
Source: www.empr.comCategories: General Medicine NewsTweet-
Atacicept significantly reduced proteinuria in patients with immunoglobulin A nephropathy. https://t.co/c5YnBdoYKh https://t.co/1kn5Y958uV
-
-
Mashup Score: 0Calpain-2 Targeting Antisense Oligonucleotide Fast Tracked for ALS - 1 month(s) ago
A phase 1 trial, LUMINA, is currently underway and is evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of AMX0114 in approximately 48 patients with ALS.
Source: www.empr.comCategories: General Medicine NewsTweet-
An investigational ALS treatment, that is currently being assessed in a trial of 48 patients, has been Fast Tracked. https://t.co/fhKGPcK2DB https://t.co/t6iRH167kL
-
-
Mashup Score: 0Clinical Challenge: Progressive Hair Loss in Woman - 1 month(s) ago
A 41-year-old woman comes to the office with a progressive history of hair loss over the past year. Can you make the correct diagnosis?
Source: www.empr.comCategories: General Medicine NewsTweet-
This week's clinical challenge is a woman experiencing progressive hair loss. Can you make the correct diagnosis? https://t.co/mhFyCzKkLV
-
-
Mashup Score: 0FDA’s New COVID-19 Vaccine Approval Policy May Limit Future Access - 2 month(s) ago
According to Makary and Prasad, the US’s adoption of a “one-size-fits-all” guidance for COVID-19 vaccination departs from other high income countries that limit recommendations to older adults or those at high risk.
Source: www.empr.comCategories: General Medicine NewsTweet-
New FDA chiefs outline regulatory framework for COVID-19 vaccines. https://t.co/319VLB6TPJ https://t.co/YbR3HNHC2n
-
RFK Jr. said he made the decision to remove the ACIP members in order to "reestablish public confidence in vaccine science." However, the AAP said the move "undermines the trust pediatricians have built over decades with our parents." https://t.co/38AIvDcwHg https://t.co/Zk7qclkhRU